Edesa Biotech is trading at $5.88 (12% up) after a volatile week with no clear news catalyst identified.
- The move follows a 5.3% drop during the July 24 regular session and double-digit declines earlier in the week.
- The after-hours jump likely reflects opportunistic trading and low liquidity rather than fresh earnings, news, or analyst actions.